Pharmaceutical manufacturer recalls generic blood pressure drug over impurities (Full List)

*Sun Pharmaceutical Industries, New Jersey, United States, is recalling 34,000 bottles of Diltiazem Hydrochloride extended-release capsules for containing impurities

Emmanuel Akosile | ConsumerConnect

Sun Pharmaceutical Industries, Inc. of Cranbury, New Jersey, United States (US), is recalling 34,000 bottles of Diltiazem Hydrochloride extended-release capsules.

ConsumerConnect reports the generic drug is used to treat high blood pressure (BP) and chest pain. Diltiazem is a medicine used to treat high blood pressure. If you have high blood pressure, taking diltiazem helps to prevent future heart disease, heart attacks and strokes.

Diltiazem is also used to prevent chest pain caused by angina as well as Raynaud’s phenomenon. It can also be used to help heal an anal fissure, according to UK’s NHS.

The pharmaceutical company said it is recalling the drug because certain lots of the prescription drug failed impurity tests at a US Food and Drug Administration (FDA) laboratory.

The recall includes:

• Lot # HAC3120A: 6912 Bottles
• Lot # HAC3121A: 6792 Bottles
• Lot # HAC4460A: 6816 Bottles
• Lot # HAD0365A: 6744 Bottles
• Lot # HAD1452A: 6840 Bottles

The drugs were distributed throughout the United States, and have expiration dates ranging from April 2023 to February 2024.

Sun Pharma first announced the recall last month but this week upgraded it to Class 2, meaning the product “may cause” temporary health issues that, in rare cases, could be serious, report said.